Table 1 Characteristics of included studies
First author name, year of publication | Journal | Searched databases | Date of search | Number of included studies | Total sample size | Reported biomarkers | Checklist used for quality assessment of included original studies | Funding status | Previous registered protocol | Software of analysis | Model of analysis | Amstar 2 score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zuo [13] | International Journal of Cardiology | PubMed, Embase, Cochrane Library, and CBM (Chinese Biomedical Literature database) | April 18, 2016 | 18 | 13,084 | UA | NOS | No | No | STATA | Random-effects model | Low quality |
Javid [8] | Annals of medicine and surgery | PubMed, Scopus, and Web of Science | November 2022 | 4 | 1346 | GGT | JBI | No | No | CMA | Random-effects model | Low quality |
Wu [9] | Angiology | PubMed, EMBASE, Google Scholar, Clinical Trials, and Science Direct | June 3, 2020 | 26 | 29,454 | CRP, hsCRP, NLR, PLR, HCT, RDW | NOS | No | No | Revman | Random effect model for heterogenic and fix effect model for non-heterogenic studies | Low quality |
Wu [14] | Medicine | PubMed, Embase, Cochrane Central Register of Controlled Trials Library, and Web of Science | March 9, 2022 | 12 | 7789 | BNP | QUADAS-2 | No | PROSPERO (CRD42022318275) | STATA, Review Manager, and MetaDisc | Random effects model | High quality |
Zhang [15] | Angiology | PubMed, EMBASE, Google Scholar, Clinical Trials, and ScienceDirect | July 13, 2018 | 18 | 16,171 | Alb, Uric acid, BUN | NOS | No | No | Revman | Random effect model for heterogenic and fix effect model for non-heterogenic studies | Critically Low-quality |
Wang [16] | Canadian Journal of Cardiology | PubMed, MEDLINE, EMBASE, Web of Science, ClinicalTrials.gov, Cochrane Library, and Google Scholar | November 2014 | 14 | 1520 | NGAL | QUADAS | Yes | No | STATA | Random effect model for heterogenic and fix effect model for non-heterogenic studies | Critically Low quality |
Li [17] | Journal of Interventional Cardiology | Medline, Embase, ClinicalTrials.gov, Cochrane Library database, and the China National Knowledge Infrastructure (CNKI) | November 31, 2019 | 9 | 946 | uKIM-1 | QUADAS-2 | Yes | No | STATA | Bivariate mixed-effects regression | Critically Low-quality |
Nie [18] | Angiology | PubMed, Embase, and the Cochrane library | November, 2020 | 6 | 16,899 | Contrast media volume to creatinine clearance ratio | NOS | No | No | STATA | Random effect model | High Quality |
Li [22] | Journal of Interventional Cardiology | PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials Library | April 2020 | 9 | 2832 | BNP | QUADAS-2 | Yes | No | STATA | Bivariate random-effects regression | Critically Low quality |
Kewcharoen [20] | Cardiovascular Revascularization Medicine | MEDLINE and EMBASE | January 2020 | 8 | 10,991 | Preprocedural blood glucose | NOS and Cochrane Collaboration tool | No | No | STATA | Random effects model | Critically Low quality |
Chen [19] | Toxicology Letters | PubMed, MEDLINE, and Embase | March 2018 | 10 | 2554 | Cystatin C | QUADAS-2 | Yes | No | STATA | Bivariate meta-analysis | Critically Low quality |
Jiang [21] | Medicine | PUBMED, EMBASE, and Web of Science | September 15, 2018 | 6 | 10,452 | PLR | NOS | No | No | STATA and Revman | Random effect model for heterogenic and fix effect model for non-heterogenic studies | Low quality |